Government Affairs
Refine Search
Generics
Changes to Japan’s drug reimbursement system care are inevitable. The only questions are the extent of changes and when they will be implemented. We should have answers to these questions at year end so they can be implemented in April 2018, says P Reed Maurer, long-time Japan pharma watcher and president of International Alliances Limited in his regular column for The Pharma Letter. 15 December 2017
Pharmaceutical
US FDA commissioner Scott Gottlieb has provided a review of current scheduled regulatory developments within the purview of the agency. 15 December 2017
Pharmaceutical
The UK and European Union (EU) have made enough progress to move on to a second phase of Brexit talks focusing on trade, they announced last week. 13 December 2017
Pharmaceutical
The news early Friday morning that Britain and the European Union had finally agreed that enough progress has been made in the Brexit talks for the UK to leave the EU, to move on to more detailed trade agreement discussions, was broadly welcomed by the pharma and biotech industry. 8 December 2017
Pharmaceutical
British lawmakers have revealed details of a new industrial strategy for the life sciences sector, aimed at supporting economic development in the wake of Brexit. 6 December 2017
Pharmaceutical
The British pharmaceutical industry’s leading trade group told a UK government committee this morning that it would favor “a pragmatic agreement” where parts of the European Medicines Agency would stay in London after Brexit. 5 December 2017
Pharmaceutical
American lawmakers meeting in a closed-door session reportedly received assurances from President Trump that he would be willing to support measures that would bolster the wobbling Obamacare exchange markets, in return for an end to the individual mandate. 29 November 2017
Pharmaceutical
The UK managing directors (MDs) of three US pharma majors have given a House of Lords Committee their views on how to make the UK more competitive in attracting investment in the life sciences. 28 November 2017
Pharmaceutical
On Thursday, The Pharma Letter reported that privately-held biotech startup Immunochina had become the latest Chinese venture to attract overseas investment as it raised 50 million renminbi ($7.5 million) in a funding round. 24 November 2017
Pharmaceutical
While many in the UK life sciences sector have looked on with concern as Brexit-backing Conservatives have pushed the nation towards exiting the European Union (EU) without even agreeing a deal with the trade bloc, the government’s promises over the past year for funding for science and health have been widely welcomed by the industry. 22 November 2017
Pharmaceutical
European heads of state have chosen Amsterdam as the new home for the European Medicines Agency post-Brexit, simultaneously ending months of speculation and the hopes of 18 other nations bidding to host the prestigious organization. 21 November 2017
Pharmaceutical
If Health Canada achieves its goal of lowering the maximum prices for drugs, the health of Canadians could suffer, shows a Viewpoint published today by the Montreal Economic Institute (MEI), an independent, non-partisan, not-for-profit research and educational organization. 15 November 2017
Pharmaceutical
Announcing his pick for the next Health and Human Services (HHS) Secretary in a Tweet on Monday, US President Donald Trump returned to the rhetoric of his sporadic outbursts on pharmaceutical product prices once more. 14 November 2017
Pharmaceutical
Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, Swiss pharma giant Roche ultimately decided to make the drug available to patients for free, according to the Brussels-based think-tank Euractiv. 4 November 2017
Pharmaceutical
The UK government has announced a new fast-track route into the National Health Service (NHS) for breakthrough medicines and technologies. 3 November 2017
Pharmaceutical
Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. 3 November 2017
Pharmaceutical
Michael Ellenbogen, who was diagnosed with younger-onset Alzheimer’s disease in 2008, was invited to give a talk to staff at a major pharma company last week. He has provided his speech to The Pharma Letter as part of his drive for urgent action to defeat the disease. 31 October 2017
Pharmaceutical
On November 20, the question of which country will host the European Medicines Agency post-Brexit will finally be settled, at the European Council’s General Affairs (Art. 50) meeting. 25 October 2017
Pharmaceutical
The leading trade group for the pharmaceuticals industry is lobbying for the federal 340B drug discount program to be constrained. 23 October 2017
Pharmaceutical
The US Federal Trade Commission (FTC) – alongside colleagues at the Food and Drug Administration (FDA) – is trying to gain an insight what impediments there are to fairness and competition in prescription drug markets. 19 October 2017
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze